full.am
  • am
  • en
  • ru
USD 390.90
EUR 444.61
RUB 4.79

Cagrilintide CAS 1415456-99-3 5MG 10MG Loss Weight Peptide

  • Կենտրոն
  • 27/12/2024 06:51

Գործակալություն

[email protected]

  • Ընկերության անվանումը

    Cagrilintide CAS 1415456-99-3 5MG 10MG Loss Weight Peptide

  • Աշխատանքային ոլորտ

    Ծառայություններ և կենցաղ

  • Գրաֆիկ

    Լրիվ աշխատանքային օր

  • Կրթություն

    Միջնակարգ

  • Փորձ

    Container: Glass Vial

    Presentation: Lyophilized Powder

    Molecular formula: C194H312N54O59S2

    Molecular weight: 4409.01 g/mol

    PubChem CID: 171397054

    CAS Number: 1415456-99-3

    Research Applications: Weight Loss and Obesity

    Type 2 Diabetes

    Glucose Regulation

    Cagrilintide is a novel, long-acting acylated amylin analogue that functions as a non-selective agonist for amylin receptors (AMYR) and the calcitonin G protein-coupled receptor (CTR). Cagrilintide is structurally similar to pramlintide but with key differences, including the lipidation of the N-terminal lysine and substitutions of three amino acids (N14E, V17R, and P37Y). These modifications are designed to improve stability and efficacy. Cagrilintide has shown promise in obesity research by significantly reducing food intake and inducing weight loss.



    Tirzepatide CAS 2023788-19-2

    Semaglutide CAS 910463-68-2

    Retatrutide CAS 2381089-83-2

    Liaglutide CAS 204656-20-2

    Whatsapp/Telegram:+86 13363081709

    [email protected]

  • Նախընտրելի սեռ

  • Նախընտրելի տարիք

  • Նկարագիր

  • Container: Glass Vial

    Presentation: Lyophilized Powder

    Molecular formula: C194H312N54O59S2

    Molecular weight: 4409.01 g/mol

    PubChem CID: 171397054

    CAS Number: 1415456-99-3

    Research Applications: Weight Loss and Obesity

    Type 2 Diabetes

    Glucose Regulation

    Cagrilintide is a novel, long-acting acylated amylin analogue that functions as a non-selective agonist for amylin receptors (AMYR) and the calcitonin G protein-coupled receptor (CTR). Cagrilintide is structurally similar to pramlintide but with key differences, including the lipidation of the N-terminal lysine and substitutions of three amino acids (N14E, V17R, and P37Y). These modifications are designed to improve stability and efficacy. Cagrilintide has shown promise in obesity research by significantly reducing food intake and inducing weight loss.



    Tirzepatide CAS 2023788-19-2

    Semaglutide CAS 910463-68-2

    Retatrutide CAS 2381089-83-2

    Liaglutide CAS 204656-20-2

    Whatsapp/Telegram:+86 13363081709

    [email protected]

Տարածել